Heparin bridge is associated with more post-polypectomy bleeding and emergency department visits among anticoagulated patients

Colonoscopy remains the preferred method for prevention of colorectal cancer, serving as both a screening and a therapeutic modality. With an estimated 22.4 million colonoscopies performed annually in the United States and another 11 million individuals estimated to be taking anticoagulant therapy, gastroenterologists will increasingly need to be familiar with these medications and understand the associated adverse events It is essential for clinicians to understand, and more importantly reduce, procedure-associated adverse events, including the most common post-polypectomy bleeding Reported to occur in approximately 0.3-10% of cases overall, the incidence of post-polypectomy bleeding related specifically to a population of patients on anticoagulants is less well defined